BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vij M, Rammohan A, Rela M. Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection. World J Hepatol 2022; 14(8): 1541-1549 [PMID: 36157865 DOI: 10.4254/wjh.v14.i8.1541]
URL: https://www.wjgnet.com/1948-5182/full/v14/i8/1541.htm
Number Citing Articles
1
Hanlin L. Wang. Asymptomatic Allograft Fibrosis in Pediatric Liver Transplantation: Potential Clinical ImplicationsTransplantation 2023; 107(11): 2314 doi: 10.1097/TP.0000000000004604
2
Shilpa Chawla, Subholakshmi Choudhury, Amitava Das. Bioengineered MSCGFPCxcr2-Mmp13 Transplantation Alleviates Hepatic Fibrosis by Regulating Mammalian Target of Rapamycin SignalingAntioxidants & Redox Signaling 2024;  doi: 10.1089/ars.2023.0390
3
Samuele Iesari, Francesca Laura Nava, Ilaria Elena Zais, Laurent Coubeau, Mariano Ferraresso, Evaldo Favi, Jan Lerut. Advancing immunosuppression in liver transplantation: A narrative reviewHepatobiliary & Pancreatic Diseases International 2024;  doi: 10.1016/j.hbpd.2024.03.001
4
Youwei Zhao, Lijun Wang, Man Xie, Wei Rao. Progress in the diagnosis and treatment of graft fibrosis after liver transplantationPortal Hypertension & Cirrhosis 2024; 3(1): 22 doi: 10.1002/poh2.70
5
Madhumitha Rabindranath, Rita Zaya, Khairunnadiya Prayitno, Ani Orchanian-Cheff, Keyur Patel, Elmar Jaeckel, Mamatha Bhat. A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to DiagnosisTransplantation Direct 2023; 9(11): e1547 doi: 10.1097/TXD.0000000000001547
6
S. E. Voskanyan, V. E. Syutkin, A. I. Sushkov, Yu. V. Voskanyan, A. Yu. Veselkova. Liver allograft pathology in the late post-transplant periodTransplantologiya. The Russian Journal of Transplantation 2023; 15(3): 359 doi: 10.23873/2074-0506-2023-15-3-359-375
7
Nourhan Badwei. Hepatic allograft rejection after liver transplantation: Clinicopathological debates!iLIVER 2023; 2(2): 116 doi: 10.1016/j.iliver.2023.05.003